Galileo - Biotech Innovation Fund IM Fonds
139,47
USD
-0,06
USD
-0,04
%
NAV
Werbung
Top Holdings
Chart
Tabelle
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 8,95% |
| Arcellx Inc | US03940C1009 | 8,30% |
| Krystal Biotech Inc | US5011471027 | 7,83% |
| Stoke Therapeutics Inc | US86150R1077 | 6,76% |
| BioNTech SE ADR | US09075V1026 | 4,16% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,07% |
| Oxford BioMedica PLC | GB00BDFBVT43 | 3,52% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,44% |
| Gilead Sciences Inc | US3755581036 | 2,97% |
| CRISPR Therapeutics AG | CH0334081137 | 2,83% |
| Sonstige | 47,16% |
